Sudden cardiac death (SCD)VFventricular arrythmiasventricular fibrillation
…Introduction Sudden cardiac death (SCD) is a leading cause of mortality worldwide, most commonly caused…
23,712articles mentioning diseases
125,551disease mentions
18,081distinct diseases extracted
0%of mentions human-reviewed
All extracted diseases
Showing 1,081–1,140 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
Pancreatic exocrine insufficiency7Pectus Excavatum7Post-Intensive Care Syndrome7Prostate cancer (PCa)7Pulmonary Disease7Pulmonary embolism (PE)7Retinitis pigmentosa7Retinopathy of prematurity (ROP)7Sjögren’s disease (SjD)7Steatotic liver disease (SLD)7Tetralogy of Fallot7Transient ischemic attack7Ventilator-associated pneumonia (VAP)7acute ischemic strokes7anterior circulation stroke7autoimmune thyroiditis7esophageal squamous cell carcinoma7haematological malignancy7intraventricular haemorrhage7life-limiting illnesses7neurological diseases7MEs6Fragility fracture6cACLD6iCCA6CSCC6Bacterial infections6Albuminuria6Achondroplasia6MD6PPD6Human Immunodeficiency Virus6Gastroschisis6PCC6CML6Spina bifida6Testicular cancer6haemolytic anaemia6Aphasia6Chronic cough6DMVO6Lung fibrosis6Parkinsonism6Bone Metastases6Musculoskeletal pain6DMEK6Eye disease6KOA6Periodontitis6Dysarthria6FMS6MEVO6MMD6BCC6CT266Chylothorax6Turner Syndrome6renal dysfunction6DRE6Diabetic nephropathy6
Articles mentioning diseases
23,712 articles · page 627 of 1976myocardial infarctionMIfibrosisMI-related4’-O-Methylochnaflavone4’-MFLY2940024’-MF-induced
…iomyocyte proliferation is a promising therapeutic strategy for myocardial infarction (MI). 4’-O-Methylochnaflavone (4’-MF), a natural compound, has …
atrial fibrillationASAFmyocardial infarctionTAVRPubMedSurgical aortic valve replacementSAVRtranscatheter aortic valve replacementEmbase
… follow-up points. TAVR markedly reduced new-onset or worsening atrial fibrillation (AF) at 30 days (RR: 0.19; P < 0.00001), 1 year (RR: 0.24; P < …
Maternal cardiac diseaseRheumatic heart diseasecardiomyopathyUganda Heart InstituteBarts Heart CentreKawempe National Referral Hospital
…Introduction Maternal cardiac disease is a major contributor to morbidity and mortality in East Afric…
atrial fibrillationstroke
…thmias than traditional short-duration Holter monitoring. While atrial fibrillation can often be managed directly by stroke teams, interpretation o…
Non-ischaemic cardiomyopathyNICMnational centre
…Introduction Non-ischaemic cardiomyopathy (NICM) represents a heterogenous group of myocardial disorders …
diabetes mellitusacute coronary syndromeACSbempedoic acidezetimibePCSK9 inhibitorsstatinsUK district general hospitalPCSK9
… or optimisation of secondary causes of hyperlipidaemia such as diabetes mellitus. The model was applied retrospectively to 103 consecutive ACS p…
refractory anginamyocardial ischaemiaEssex Cardiothoracic Centre
… the care they received.Conclusion CSR implantation for chronic refractory angina is a safe procedure, effective at improving the symptoms and qu…
HFheart failureACZAcetazolamidefurosemide
…r more consecutive days based on European Society of Cardiology HF guidelines. Patients were split into responders and non-respond…
OMIacute coronary syndromeGolden Jubilee National HospitalGJNH
…3) without angiographyWe defined OMI as the following:Confirmed OMI: Acute occlusive culprit lesion with Thrombolysis in Myocardial…
myocardial infarctionMIBeta-blockersPubMedEmbaseBeta-blocker therapyScopus
…Introduction Beta-blockers are routinely prescribed following myocardial infarction (MI) due to established mortality benefit in patients with redu…
pulmonary fibrosisdiabetescardiovascular diseaseCVDaortic stenosismetforminIL-6IL-1βIL-1
…iovascular disease (CVD) and comorbidities such as diabetes and pulmonary fibrosis (Maillard et al., 2019; Semba et al., 2010). Currently FN3K and…